TGFBR1 and cardiac hypertrophy: Moreover, 12 weeks after aortic constriction, Tgfbr1/2 knockout mice demonstrated reduced ventricular fractional shortening, preserved diastolic function and reduced cardiac hypertrophy, highlighting the targeting of the TGF-β pathway as a viable strategy to reduce cardiac fibrosis [80].